ClinicalTrials.gg
Sign In

Pneumonia, Bacterial clinical trials

The registry lists 153 studies for Pneumonia, Bacterial across more than 10 countries. 27 are recruiting or about to start. 91 of them are mainly about Pneumonia, Bacterial (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-27. Counting its 2 narrower conditions too, such as Pneumonia, Pneumococcal: 214 studies, 32 open.

Get an email when these change. Save the Pneumonia, Bacterial studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
94
Recruiting
18
Status unknown
12
Terminated
9
Not yet recruiting
8
Active, not recruiting
6

Phase

Phase 3
38
Phase 2
26
Phase 1
12
Phase 4
9

Where

United States
50
France
22
Spain
14
Taiwan
12
Germany
12
Italy
10

Who runs them

GlaxoSmithKline (6) · Wyeth is now a wholly owned subsidiary of Pfizer (5) · Pfizer (4) · Massachusetts General Hospital (4) · Assistance Publique - Hôpitaux de Paris (3) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (3) · Merck Sharp & Dohme LLC (3) · Cumberland Pharmaceuticals (3)

What is being tested here

Drugs under test in Pneumonia, Bacterial studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Pn-MAPS30plus104
Amikacin101
MP-101101
Methylprednisolone Hemisuccinate111
Methylprednisolone111
Tigecycline035
Levofloxacin034
Imipenem023
Cilastatin023
Doripenem013

Drug classes tested here Beta-lactamase inhibitors 3

Coming up

6phase 3 studies under way
11studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 18 Pneumonia, Bacterial studies recruiting now, 12 (67%) set no upper age limit and 2 (11%) stop at 75 or younger. 2 (11%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (6%) take healthy volunteers.

Recruiting studies that take each age, of 18
AgeWomenMen
101 (6%)1 (6%)
1815 (83%)15 (83%)
3016 (89%)16 (89%)
4016 (89%)16 (89%)
5016 (89%)16 (89%)
6516 (89%)16 (89%)
7516 (89%)16 (89%)
8514 (78%)14 (78%)

Across all 153 studies, recruiting or not: 23% stop at 75 or younger and 18% at 65; 21% take children; 1% are for women only and 0% for men only; 11% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Pneumonia, Bacterial studies take

Of 15 phase 3 interventional studies under Pneumonia, Bacterial, half reached primary completion within 25 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 325 mo15–45 · 15 studies——
Interventional, no phase24 mo17–39 · 19 studies——
Observational24 mo14–49 · 22 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 153. Browse all 153 → or search them.